November Pharma and CRO Spatial Summit
View On Demand
Advancing Standard Tissue Analysis Practices
Don’t miss out on the opportunity to hear the first rollout of the NanoString GeoMx® DSP Best Practices Guidance as a cross-industry Pharma and CRO collaboration initiative.
The last NanoString Pharma and CRO Spatial summit focused on scaling GeoMx® workflows for large studies in biopharma. We will continue the next Summit on this topic and will hear from Contract Research Organizations (CROs), and their analytical verification approaches to support drug discovery and development studies.
If you are a current GeoMx® DSP user or are interested in learning about the execution of spatial biology studies, join us to learn more about:
- Best practices for implementation of biopharma studies using GeoMx
- Considerations for morphology marker and ROI selection strategies
- Biopharma applications
- Analytical verification studies
The CosMx™ SMI and decoder probes are not offered and/or delivered to the Federal Republic of Germany for use in the Federal Republic of Germany for the detection of cellular RNA, messenger RNA, microRNA, ribosomal RNA and any combinations thereof in a method used in fluorescence in situ hybridization for detecting a plurality of analytes in a sample without the consent of the President and Fellows of Harvard College (Harvard Corporation) as owner of the German part of EP 2 794 928 B1. The use for the detection of cellular RNA, messenger RNA, microRNA, ribosomal RNA and any combinations thereof is prohibited without the consent of the President and Fellows of Harvard College (Harvard Corporation).